Skip to main content

Nasdaq IPOs

Cancer biotech Codiak BioSciences prices IPO at $15 midpoint

5 years 11 months ago
Codiak BioSciences, an early stage biotech developing novel exosome therapeutics for cancers, raised $83 million by offering 5.5 million shares at $15, the midpoint of the $14 to $16 range.  Codiak BioSciences plans to list on the Nasdaq under the symbol CDAK. Goldman Sachs
Renaissance Capital

Cancer biotech Codiak BioSciences prices IPO at $15 midpoint

5 years 11 months ago
Codiak BioSciences, an early stage biotech developing novel exosome therapeutics for cancers, raised $83 million by offering 5.5 million shares at $15, the midpoint of the $14 to $16 range.  Codiak BioSciences plans to list on the Nasdaq under the symbol CDAK. Goldman Sachs,
Renaissance Capital

ASMA Capital's SPAC Global SPAC Partners files for a $200 million IPO

5 years 11 months ago
Global SPAC Partners, a blank check company formed by ASMA Capital targeting businesses in MENA and South Asia, filed on Tuesday with the SEC to raise up to $200 million in an initial public offering. The Claymont, DE-based company plans to raise $200 million by offering 20 mill
Renaissance Capital

ASMA Capital's SPAC Global SPAC Partners files for a $200 million IPO

5 years 11 months ago
Global SPAC Partners, a blank check company formed by ASMA Capital targeting businesses in MENA and South Asia, filed on Tuesday with the SEC to raise up to $200 million in an initial public offering. The Claymont, DE-based company plans to raise $200 million by offering 20 milli
Renaissance Capital
Checked
21 minutes ago
This feed is responsible for generating the rss feed related to the topic IPOs
Subscribe to Nasdaq IPOs feed